永久的人工皮膚の世界市場2019-2023

◆英語タイトル:Global Permanent Artificial Skin Market 2019-2023
◆商品コード:IRTNTR30746
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年1月25日
◆ページ数:103
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、永久的人工皮膚の世界市場について調査・分析し、市場概要、市場環境、永久的人工皮膚市場規模、エンドユーザー別(病院、その他ヘルスケアセンター)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・永久的人工皮膚の世界市場概要
・永久的人工皮膚の世界市場環境
・永久的人工皮膚の世界市場動向
・永久的人工皮膚の世界市場規模
・永久的人工皮膚の世界市場:業界構造分析
・永久的人工皮膚の世界市場:エンドユーザー別(病院、その他ヘルスケアセンター)
・永久的人工皮膚の世界市場:地域別市場規模・分析
・永久的人工皮膚の北米市場規模・予測
・永久的人工皮膚のヨーロッパ・中東・アフリカ市場規模・予測
・永久的人工皮膚のアジア太平洋市場規模・予測
・永久的人工皮膚の主要国分析
・永久的人工皮膚の世界市場:意思決定フレームワーク
・永久的人工皮膚の世界市場:成長要因、課題
・永久的人工皮膚の世界市場:競争環境
・永久的人工皮膚の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About this market
Increasing initiatives to raise awareness of skin and tissue donation to drive market growth. Organizations such as Donate Life America are conducting an increasing number of awareness programs to increase the awareness of skin ailments that require replacement surgeries and the need for skin donation. Donate Life America is a non-profit organization that promotes the donation of organs, eyes, and tissue. The organization partners with other organizations such as the American Association of Tissue Banks to educate the population across the US about tissue donation and encourage people to donate tissue. Technavio’s analysts have predicted that the permanent artificial skin market will register a CAGR of almost 19% by 2023.
Market Overview
Availability of cost-effective treatment in developing countries
The global permanent artificial skin market is not regulated in developing countries in South America and APAC. The high availability of certified doctors and the low cost of treatment is driving the growth of permanent artificial skin market in these regions. Countries such as China, India, Brazil, and South Korea are among the top 10 countries in the world in terms of the number of certified cosmetic surgeons.
Lack of accessibility and affordability of diagnostic test centers
Advanced diagnostic centers that offer a wide range of diagnostic tests are widely present in developing countries. However, there is a shortage of such centers in developing countries, where the disease burden is high. As a result, numerous patients with chronic diseases remain undiagnosed due to the lack of availability of diagnostic centers.
For the detailed list of factors that will drive and challenge the growth of the permanent artificial skin market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including MiMedx and Solsys Medical the competitive environment is quite intense. Factors such as the increasing initiatives to raise awareness of skin and tissue donation and the expansion of aircraft manufacturing facilities, will provide considerable growth opportunities to permanent artificial skin manufactures. Avita Medical, EUCARE PHARMACEUTICALS, Integra LifeSciences, MiMedx, and Solsys Medical are some of the major companies covered in this report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Hospitals – Market size and forecast 2018-2023
• Other healthcare centers – Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Technological advances
• Strategic alliances
• Increasing initiatives to raise awareness of skin and tissue donation
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Avita Medical
• EUCARE PHARMACEUTICALS
• Integra LifeSciences
• MiMedx
• Solsys Medical
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: End-user – Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Hospitals – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Hospitals – Year-over-year growth 2019-2023 (%)
Exhibit 21: Other healthcare centers – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Other healthcare centers – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by end-user
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America – Year-over-year growth 2019-2023 (%)
Exhibit 29: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 31: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 33: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Avita Medical – Vendor overview
Exhibit 44: Avita Medical – Business segments
Exhibit 45: Avita Medical – Organizational developments
Exhibit 46: Avita Medical – Geographic focus
Exhibit 47: Avita Medical – Key offerings
Exhibit 48: EUCARE PHARMACEUTICALS – Vendor overview
Exhibit 49: EUCARE PHARMACEUTICALS – Product segments
Exhibit 50: EUCARE PHARMACEUTICALS – Key offerings
Exhibit 51: Integra LifeSciences – Vendor overview
Exhibit 52: Integra LifeSciences – Business segments
Exhibit 53: Integra LifeSciences – Organizational developments
Exhibit 54: Integra LifeSciences – Geographic focus
Exhibit 55: Integra LifeSciences – Segment focus
Exhibit 56: Integra LifeSciences – Key offerings
Exhibit 57: MiMedx – Vendor overview
Exhibit 58: MiMedx – Business segments
Exhibit 59: MiMedx – Key offerings
Exhibit 60: Solsys Medical – Vendor overview
Exhibit 61: Solsys Medical – Business segments
Exhibit 62: Solsys Medical – Key offerings
Exhibit 63: Validation techniques employed for market sizing




【掲載企業】

Avita Medical、EUCARE PHARMACEUTICALS、Integra LifeSciences、MiMedx、Solsys Medical

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[永久的人工皮膚の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆